Innovative funding partner throughout the growth life-cycle

Latest developments

News, Portfolio 22/09/2022              

As demand for compliance and security soar, DataGuard tops up with €61 million

While digital transformation and the rise of cloud computing have produced vast amounts of data. Meanwhile, the EU has spearheaded a global push for more robust data protection and enforcement,…
News, Portfolio 08/09/2022              

Scopio Labs Launches World’s First Digital Application for Bone Marrow Aspirate Imaging and Review

Scopio's CE-Marked Full-Field Bone Marrow Aspirate™ Application provides an enhanced hematology workflow by utilizing AI and imaging of vast numbers of cells to overcome limitations of manual microscopy TEL AVIV, Israel, Sept.…
News, Portfolio 22/08/2022              

Pi-Cardia Successfully Performs Mitral Valve Splitting With ShortCut(TM)

 Pi-Cardia Ltd., a global leader in the development of non-implant, catheter-based solutions for treating heart valves, announced today a successful First-In-Human treatment of the mitral valve with the ShortCut™ Mitral…

Subscribe to our mailing list

Get our newsletter, Kreos updates and information on our events right to your mailbox.

Market Leading Growth Debt Investor for +22 years

Kreos Capital provides innovative and flexible debt solutions to equity-backed, pan-European and Israeli high-growth companies in the technology and healthcare sectors.

For over 22 years, our sole focus has been to support our ambitious ecosystem with personal, adaptable and responsive financing through every stage of the growth life cycle – from entry level through to late-stage growth including pre and post-IPO.